- Home
- CRDF vs GENC Comparison
CRDF vs GENC Comparison
Compare CRDF & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- GENC
- Stock Information
- Founded
- CRDF 1999
- GENC 1894
- Country
- CRDF United States
- GENC United States
- Employees
- CRDF N/A
- GENC N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- GENC Construction/Ag Equipment/Trucks
- Sector
- CRDF Health Care
- GENC Industrials
- Exchange
- CRDF Nasdaq
- GENC Nasdaq
- Market Cap
- CRDF 210.2M
- GENC 210.9M
- IPO Year
- CRDF N/A
- GENC N/A
- Fundamental
- Price
- CRDF $3.66
- GENC $15.94
- Analyst Decision
- CRDF Strong Buy
- GENC
- Analyst Count
- CRDF 5
- GENC 0
- Target Price
- CRDF $10.50
- GENC N/A
- AVG Volume (30 Days)
- CRDF 1.5M
- GENC 25.0K
- Earning Date
- CRDF 08-07-2025
- GENC 08-08-2025
- Dividend Yield
- CRDF N/A
- GENC N/A
- EPS Growth
- CRDF N/A
- GENC N/A
- EPS
- CRDF N/A
- GENC 0.99
- Revenue
- CRDF $587,000.00
- GENC $113,166,000.00
- Revenue This Year
- CRDF N/A
- GENC N/A
- Revenue Next Year
- CRDF N/A
- GENC N/A
- P/E Ratio
- CRDF N/A
- GENC $15.26
- Revenue Growth
- CRDF N/A
- GENC 7.70
- 52 Week Low
- CRDF $2.01
- GENC $10.80
- 52 Week High
- CRDF $5.64
- GENC $24.88
- Technical
- Relative Strength Index (RSI)
- CRDF 58.81
- GENC 58.18
- Support Level
- CRDF $3.07
- GENC $13.68
- Resistance Level
- CRDF $3.24
- GENC $15.45
- Average True Range (ATR)
- CRDF 0.23
- GENC 0.74
- MACD
- CRDF 0.00
- GENC -0.00
- Stochastic Oscillator
- CRDF 67.96
- GENC 81.62
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.